{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:59:14Z","timestamp":1793386754032,"version":"4.5.0"},"reference-count":38,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1080\/17474086.2025.2591606","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T16:03:11Z","timestamp":1763395391000},"page":"127-132","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Beyond progression-free survival (PFS): time to next treatment (TTNT) as a patient-centered metric of clinical benefit in chronic lymphocytic leukemia (CLL)"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2795-6507","authenticated-orcid":false,"given":"Stefano","family":"Molica","sequence":"first","affiliation":[{"name":"Hull University Teaching Hospitals NHS Trust","place":["Hull, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.22.2119"},{"issue":"4","key":"e_1_3_5_5_1","first-page":"1121","article-title":"Clinical endpoints in oncology - a primer","volume":"11","author":"Delgado A","year":"2021","unstructured":"Delgado A, Guddati AK. Clinical endpoints in oncology - a primer. Am J Cancer Res. 2021 Apr 15;11(4):1121\u20131131","journal-title":"Am J Cancer Res"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25561"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2271170"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02483-5"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.3748"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024631"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01991-5"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.07.004"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.08.004"},{"key":"e_1_3_5_14_1","volume-title":"Poster 627. European Hematology Association 2023 Congress","author":"Kipps T","year":"2023","unstructured":"Kipps T, Owen C, Flinn IW, et al. Long-term outcomes with continuous ibrutinib in patients with CLL: analysis of time to progression. Poster 627. European Hematology Association 2023 Congress; 2023 Jun 9; Frankfurt (DE)."},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025028570"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.01192"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0436"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2148218"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00975"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213093"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00452-7"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014488"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01485-x"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024015180"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025525"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03355"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00166"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2024.100047"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2025.2482132"},{"key":"e_1_3_5_31_1","unstructured":"Endpoints used in relative effectiveness assessment: surrogate endpoints. 2025 Nov 20. Available from: https:\/\/www.eunethta.eu\/wp-content\/uploads\/2018\/01\/Endpoints-used-in-Relative-Effectiveness-Assessment-Surrogate-Endpoints_Amended-JA1-Guideline_Final-Nov-2015.pdf2015"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpo.2022.100364"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.07.004"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022269"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.6400"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn656"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14826"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082311"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3165_594"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.9124"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2025.2591606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:40:47Z","timestamp":1770025247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2025.2591606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1080\/17474086.2025.2591606"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2025.2591606","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}